The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction


Creative Commons License

Paitazoglou C., ÖZDEMİR R., Pfister R., Bergmann M. W. , Bartunek J., KILIÇ T. , ...Daha Fazla

EUROINTERVENTION, cilt.15, ss.403-410, 2019 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 15 Konu: 5
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4244/eij-d-19-00342
  • Dergi Adı: EUROINTERVENTION
  • Sayfa Sayıları: ss.403-410

Özet

Aims: Reducing elevated left atrial pressure with an atrial septum shunt device is a possible treatment option in symptomatic heart failure patients. This study aimed to investigate the safety and feasibility of the Atrial Flow Regulator (AFR) in heart failure patients.